Skip to main content
Clinical Trials/NCT02330237
NCT02330237CompletedPhase 2

Safety and Efficacy of Natural Gel Combination and Hair Mask of Plant Origin in Patients With Psoriasis: A Randomized, Double-Blind, Placebo (Vehicle) Controlled

Secret of Youth1 site in 1 country45 target enrollmentStarted: January 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
45
Locations
1
Primary Endpoint
Modified Psoriasis Assessment severity index

Study Overview

Brief Summary

The aim of the study is to evaluate the safety and the therapeutic activity of the combination of Natural Gel combination and hair mask of plant origin in patients with mild to moderate plaque psoriasis.

Detailed Description

This is a random, double blind placebo -vehicle- controlled study. Patients recruiting and inclusion into the study is well defined. Expert on site monitoring will assure execution of all assignments as detailed in the protocol (screening, consent form, double-blind group assignment) .

Statistical analysis

  • It is calculated that 52 patients will be needed for this study.
  • Type I error probability associated with this test is 0.05 .
  • Uncorrected chi square will be used to assess changes in the measured variables.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Subjects with stable (for at least 6 months), mild to moderate (less than 10% of the skin surface area) plaque psoriasis.
  • Male and female ≥ 18 years old.
  • Subject is capable of giving a written informed consent.

Exclusion Criteria

  • Subjects treated by topical or photo or systemic anti psoriatic therapy during 4 weeks prior to the study.
  • Subjects treated with Biological products for psoriasis for the last 3 months prior to starting the present study.
  • Subjects with any other type of psoriasis but vulgaris (plaque ).
  • Use of investigational agents < 30 days prior to the study.
  • Low compliance.
  • Subjects who are mentally or physically unable to comply with all aspects of the study.
  • Pregnant women.
  • Known allergic reaction to fragrance or any ingredient of the test products.
  • Other inflammatory skin disease in the treatment area that may confound the evaluation of the psoriasis.
  • A medical condition that may put the patient at a general risk and therefore would prevent participation in the clinical trial.

Arms & Interventions

patients

Active Comparator

natural gels

Intervention: natural gels (Drug)

subjects

Placebo Comparator

These patients will receive that placebo (vehicle) products.

Intervention: Placebo (Drug)

Outcomes

Primary Outcomes

Modified Psoriasis Assessment severity index

Time Frame: up to 16 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Natural Gels for Treatment of Plaque... | Clinical Trial